Upload
ashlo2009
View
226
Download
0
Embed Size (px)
Citation preview
8/3/2019 Today3 [Compatibility Mode]
1/62
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
2/62
Prof in Forensic Medicine and Clinical Toxicology
Department
AND
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
3/62
8/3/2019 Today3 [Compatibility Mode]
4/62
OUTLINE OF LECTURE
Definitions and classification of poisons
Phases of poisoning
Factors affecting the severity of poisoning
Diagnosis
Treatment
8/3/2019 Today3 [Compatibility Mode]
5/62
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
6/62
Enhancement of eliminationEnhancement of elimination
Lung (Oxygen + CO2)
Intestine (purgatives)
Lung (Oxygen + CO2)
Intestine (purgatives)
e repeate oses o . .
Kidney (Diuresis + dialysis)
e repeate oses o . .
Kidney (Diuresis + dialysis)
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
7/62
dose activated charcoal-Repeat
Dose: 20-30 or 0.5-1 k ever 4 hours are
given orally or via gastric tube.
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
8/62
dose activated charcoal-RepeatReduces the blood concentration of a toxin by
either: Interrupting enterohepatic or enteroenteric circulation
(e.g. morphine, dapsone, digitoxin, carbamazepines, and
TCA).
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
9/62
dose activated charcoal-RepeatReduces the blood concentration of a toxin by
either:
Allow toxin diffusion passively from the
(gasterointestinal dialysis) as theophylline.
Adsorption ofdrugs still present in the gut
as drugs forming concretions (salicylate),SR preparations (theophylline), and drugs
slowing the GIT motility (anticholinergics).
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
10/62
dose activated charcoal-RepeatIndications:
Shorten the half-life of:
Carbamazepine
DigitoxinPhenytoin
Phenobarbital
Salicylate
Theophylline.
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
11/62
dose activated charcoal-RepeatAdverse effects:
Serious fluid and electrolyte disturbance
secondary to large-volume diarrhea, especially
-
used.
It should not be used in patients with ileus or
obstruction.
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
12/62
DiuresisDiuresis
Fluid
Osmotic
Fluid
Osmotic
orce a a ne + ac corce a a ne + ac c
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
13/62
DiuresisDiuresis
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
14/62
Indications of forced diuresis
The poison excreted mainly in urine.
Low protein bound.
Weak acid or weak alkali.
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
15/62
Contraindications of forced diuresis
The poison not excreted in urine in active
form.
Shock.
Heart ai ure. Renal dysfunction.
The poison produces pulmonary edema.
Lack facilities to monitor plasma electrolytes
level.
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
16/62
Alkaline dieresis Salicylate, lithium, meprobamate and
phenobarbital are weak acids. By promoting an alkaline urine (PH 7-8),
Drugs wi ecome more ionize in t e istatubular lumen, which will slow tubular re-
absorption and allow a larger fraction of the
drug to be excreted without being reabsorbedback into the body.
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
17/62
Alkaline dieresis Give sodium bicarbonate 1-2 mEq/kg in 1L
saline / hour every 3-4 hours followed byinfusion of 500 cc dextrose 5% and saline
.
Correct hypokalemia by adding 10 20 mEq/L
IV.
It enhances elimination of polar drugs by iontrapping.
Requires normal renal.14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
18/62
Alkaline dieresis
Maintain: Urine pH at 7-8.
- .
Blood pH at 7.35-7.45.
Electrolytes and correct any abnormality (e.g.
hypokalemia).
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
19/62
Alkaline dieresis
Indications: Salicylate overdose.
.
Lithium overdose.
Poisons producing hemolysis or
rhabdomyolysis.
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
20/62
Alkaline dieresisAdverse effects:
Fluid overload. Acid-base abnormalities (alkalosis).
ectro yte a norma t es e.g. ypo a em a,hypernatremia).
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
21/62
DialysisDialysis
The poison moves against concentration
gradients across semipermeable membranes
t roug us ng: Physiologic membrane (peritoneum)
Artificial membrane (hemodialysis).
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
22/62
DialysisDialysis
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
23/62
DialysisDialysis
HemodialysisHemodialysis
hemoperfusion
Peritoneal
hemoperfusion
Peritoneal
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
24/62
HaemodialysisHaemodialysis
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
25/62
HaemodialysisHaemodialysis
Drugs and toxins flow passively across the
semipermeable membrane down aconcentration gradient into a dialysate
.
electrolyte abnormalities can be corrected
concurrently.
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
26/62
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
27/62
Indications Hemodialysis is preferred for salicylate,
phenobarbital, ethanol, and methanol whichhave the following characters:
.
Low lipid solubility (high water solubility).
Low volume of distribution.
Low plasma protein binding.
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
28/62
Adverse effects Hemorrhage (secondary to anticoagulation).
Hypotension.
Hepatitis, AIDS and other nosocomial
in ections. Thrombosis at the site of venous access.
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
29/62
HaemodialysisHaemodialysis
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
30/62
Peritoneal DialysisPeritoneal Dialysis
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
31/62
Peritoneal DialysisPeritoneal Dialysis
Dialysate fluid is infused into the
peritoneal cavity through a transcutaneous
catheter and drained off, and the procedure is
repeate w t res a ysate.The gut wall and peritoneal lining serve as
the semipermeable membrane.
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
32/62
Peritoneal DialysisPeritoneal Dialysis
Indications: The same as hemodialysis.
NB: Peritoneal dial sis is easier to er orm than
hemodialysis or hemoperfusion, but it is onlyabout 10 15% as effective.
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
33/62
Peritoneal DialysisPeritoneal Dialysis
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
34/62
HaemoperfusionHaemoperfusion
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
35/62
HaemoperfusionHaemoperfusion
During hemoperfusion, blood is drived to pass
through a cartridge coated with activatedcharcoal to which toxic agents in the blood
.
to the patient.
Anticoagulation with heparin is necessary.
Calcium & glucose monitoring should be doneas they may be adsorbed to charcoal.
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
36/62
HaemoperfusionHaemoperfusion
Indications:
Not limited by protein binding, molecularweight or water solubility.
It is the referred method for theo h lline
paraquate, carbamazepine, phenytoin,phenobarbitone which have the following
characters:
Adsorbed by activated charcoal.
Low volume of distribution.
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
37/62
HaemoperfusionHaemoperfusion
Adverse effects: Similar to those of
hemodialysis in addition to the following:
Thrombocytopenia.
Leucopenia.
Hypoglycemia. Hypocalcemia.
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
38/62
Hemoperfusion
Blood
ARTERY
or
VEINVEIN
Return
Uses hemodialysis machine - but runs blood directlythrough a charcoal- or sorbent-containing filter
rom
patientto
patient
8/3/2019 Today3 [Compatibility Mode]
39/62
Physiological antidotesNeutralise poison
Physiological antidotesNeutralise poison
Mechanism:
Antagonism
em ca n ng Immunological binding
Competition of enzyme
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
40/62
Antidotes (ANTAGONISING THE EFFECTS OF THE POISON
Antidote PoisonN-acetylcysteine acetaminophenatro ine or ano hos hate
Ca gluconate or Ca chloride Calcium channel blockersCyanide kit cyanide
Deferoxamine Iron
Fab digoxin DigoxinDimercaprol (BAL) Arsenic, mercury, lead
8/3/2019 Today3 [Compatibility Mode]
41/62
AntidotesAntidote poison
ethanol MeOH, et glycolflumazenil Benzodiazepine
Fomepizole MeOH
glucagon -blocker, CCB
Methylene blue methemoglobin
naloxone opioidsphysostigmine anticholinergic
pralidoxime organophosphate
pyridoxine isoniazid
Sodium bicarbonate TCA, cocaine, salicylates
8/3/2019 Today3 [Compatibility Mode]
42/62
Supportive treatmentSupportive treatment
Coma
Acid base disorders
Dehydration
Rhabdomyolysis
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
43/62
ComaComa
CirculationRespirationReflexes
response
Pain
response
Conscious
level
Stage
NormalNormalIntactArousableA sleep0
NormalNormalIntactWithdrawsComatoseI
NormalNormalIntactNoneComatoseII
NormalNormalAbsentNoneComatoseIII
ShockCyanosisAbsentNoneComatoseIV
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
44/62
Causes of ComaCauses of Coma
General CNS depressants: Barbiturates
Benzodiazepines, alcohols. - Cellular hypoxia: Carbon monoxide, Cyanide,
, .
- Sympatholytic agents: Clonidine,
Tetracycline, Methyldopa, Opiates.
- Others: Hypoglycemic agents, Disulfiram,Salycylates.
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
45/62
Treatment of ComaTreatment of Coma
As acute poisoning:
Give:
Dextrose (50%, 50ml IV) to correct hypoglycemia.
Thiamine (100 mg IV), to correct suspected
vitamin deficiencies.
Naloxone (0.4 mg IV) to correct respiratory
depression in acute opiate toxicity.
Perform CT scan and lumbar puncture & CSFculture to exclude traumatic, pathological or
infectious coma.14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
46/62
Hypothermia
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
47/62
Treatment Maintain the airway and assist ventilation, and
administer supplemental oxygen. Treatment of the cause (e.g. hypotension).
I t e patient is not in car iac arrest, rewarm
slowly using blankets, warm IV fluids, and
warmed-O2 inhalation to prevent
arrhythmias.
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
48/62
Hyperthermia
14/10/2011Prof Dr Ashraf M. Emara
Hyperthermia
8/3/2019 Today3 [Compatibility Mode]
49/62
Hyperthermia
Malignant hyperthermia (inherited disorder)
causes Severe hyperthermia
Rigidity
After exposure to certain anesthetic agents (e.g.
halothane and succinylcholine).
14/10/2011Prof Dr Ashraf M. Emara
Hyperthermia
8/3/2019 Today3 [Compatibility Mode]
50/62
Hyperthermia
Treatment:
A & B.
Treatment of the cause (e.g. seizures).
Shivering can be avoided by diazepam.
Cooling (external & internal core). Neuromuscular paralysis (using
nondepolarizing agent) together with,
endotracheal intubation and mechanical
ventilation is useful for severe cases.
14/10/2011Prof Dr Ashraf M. Emara
Hyperthermia
8/3/2019 Today3 [Compatibility Mode]
51/62
Hyperthermia
Treatment:
Specific drugs:
Bromocriptine in neuroleptic malignant syndrome
14/10/2011Prof Dr Ashraf M. Emara
Rhabdomyolysis
8/3/2019 Today3 [Compatibility Mode]
52/62
Rhabdomyolysis
Causes:
Prolonged immobilization on a hard surface
Excessive seizures
Hyperthermia
Direct cytotoxic effects (e.g. carbon monoxideand some snake venoms).
14/10/2011Prof Dr Ashraf M. Emara
Rhabdomyolysis
8/3/2019 Today3 [Compatibility Mode]
53/62
Rhabdomyolysis
Muscle tenderness
Pigmenturia with urine that is orthotoluidine
(Hematest) positive with few or no intact redblood cells.
Renal failure Elevated serum creatine phosphokinase (CPK)
level.
14/10/2011Prof Dr Ashraf M. Emara
Rhabdomyolysis
8/3/2019 Today3 [Compatibility Mode]
54/62
Rhabdomyolysis
Treatment:
Maintain urine flow rate (35 mL/kg/h) with
intravenous fluids. If oliguria occurred, consider a bolus of
mannitol.
Alkalinize the urine by sodium bicarbonate
(acidic urine promotes deposition of myoglobin
in the tubules). Hemodialysis may be needed, for acute renal
failure.14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
55/62
Poison Prevention Strategies
Keep all house hold poisons separate from
food. Keep all products in their original container.
A ways rea a a e s care u y e ore using
the product.
Never take or give any medication in the dark.
Dispose all toxic and medicinal products in asafe and proper manner.
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
56/62
14/10/2011Prof Dr Ashraf M. Emara
P i P i S i
8/3/2019 Today3 [Compatibility Mode]
57/62
Poison Prevention Strategies
Encourage periodic home hunts and dispose
of old medication. Never refer to medicine or vitamins as candy.
Teac c i ren never to ta e me ication
unless given by adult they know.
Once a child has been poisoned. Be alert for
repeated episodes. Teach children not eat plants.
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
58/62
14/10/2011Prof Dr Ashraf M. Emara
P i P ti St t i
8/3/2019 Today3 [Compatibility Mode]
59/62
Poison Prevention Strategies
Keep all drugs or toxic substances out of
children sight & reach; use cabinet locks.
Keep the poison control center number at
each telephone. Tanta university hospitals, Emergency
Hospital.
Emergency line : 0185103132Administrative line : 3350373
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
60/62
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
61/62
14/10/2011Prof Dr Ashraf M. Emara
8/3/2019 Today3 [Compatibility Mode]
62/62
14/10/2011Prof Dr Ashraf M. Emara